Gain Therapeutics (GANX) EBIT (QoQ) (2020 - 2026)
Gain Therapeutics (GANX) EBIT (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.40 Bn | 131.54 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.13 Bn | 78.13 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.58 Bn | 60.40 Bn | 1.37 Bn |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.08 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.30 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.97 Bn | 9.58 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - |
| 10 | Gain Therapeutics | 85.97 Mn | 85.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.55% |
| Mar 31, 2026 | -19.87% |
| Dec 31, 2025 | 6.68% |
| Sep 30, 2025 | 5.97% |
| Jun 30, 2025 | -16.48% |
| Mar 31, 2025 | -31.17% |
| Dec 31, 2024 | 25.29% |
| Sep 30, 2024 | 45.51% |
| Jun 30, 2024 | -86.92% |
| Mar 31, 2024 | 0.67% |
| Dec 31, 2023 | 9.78% |
| Sep 30, 2023 | 36.81% |
| Jun 30, 2023 | -47.83% |
| Mar 31, 2023 | -14.66% |
| Dec 31, 2022 | 3.99% |
| Sep 30, 2022 | 8.22% |
| Jun 30, 2022 | -57.41% |
| Mar 31, 2022 | -2.48% |
| Dec 31, 2021 | 30.78% |
| Sep 30, 2021 | -31.91% |